— Know what they know.
Not Investment Advice

BIOCON.BO

Biocon Limited
1W: +0.5% 1M: -1.2% 3M: -6.6% YTD: +2.3% 1Y: +2.5% 3Y: +62.7% 5Y: -17.9%
₹379.70 ($4.04)
+10.60 (+2.87%)
 
BSE · Healthcare · Biotechnology · ₹481.9B · Alpha Radar Sell · Power 37
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹481.9B ($5.1B)
52W Range295.3-424.95
Volume145,006
Avg Volume169,519
Beta0.21
Dividend₹0.50
Analyst Ratings
No analyst coverage
Company Info
CEOSiddharth Mittal
Employees16,315
SectorHealthcare
IndustryBiotechnology
IPO Date2004-04-07
Websitebiocon.com
20th KM, Hosur Road
Bengaluru 560100
IN
91 80 2808 2808
About Biocon Limited

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, the company is involved in the integrated discovery, development, and manufacturing services for small and large molecules. It serves customers in approximately 120 countries. The company was incorporated in 1978 and is headquartered in Bengaluru, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms